S T A T E O F N E W Y O R K
________________________________________________________________________
5209
2023-2024 Regular Sessions
I N S E N A T E
February 27, 2023
___________
Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when
printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to expanding the drug
take back act to include single-use and reusable electronic cigarettes
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Subdivision 2 of section 290 of the public health law, as
added by chapter 120 of the laws of 2018, is amended to read as follows:
2. "Covered drug" means any substance recognized as a drug under 21
USC § 321(g)(1), as amended, and any regulations promulgated thereunder
that is sold, offered for sale or dispensed in the state, whether
directly or through a wholesaler, in any form including prescription and
nonprescription drugs, drugs in medical devices and combination
products, brand and generic drugs and drugs for veterinary use; provided
however, covered drug SHALL ADDITIONALLY INCLUDE SINGLE-USE AND REUSABLE
ELECTRONIC CIGARETTES AS DEFINED IN SECTION THIRTEEN HUNDRED NINETY-
NINE-AA OF THIS CHAPTER; PROVIDED HOWEVER COVERED DRUG shall not
include: (a) vitamins or supplements; (b) herbal-based remedies and
homeopathic drugs, products or remedies; (c) cosmetics, soap (with or
without germicidal agents), laundry detergent, bleach, household clean-
ing products, shampoos, sunscreens, toothpaste, lip balm, antiperspi-
rants or other personal care products that are regulated as both cosmet-
ics and nonprescription drugs under the Federal Food, Drug, and Cosmetic
Act; (d) pet pesticide products contained in pet collars, powders, sham-
poos, topical applications, or other forms; (e) drugs that are biolog-
ical products as defined in subdivision twenty-seven of section sixty-
eight hundred two of the education law if the manufacturer already
provides a take back program; (f) drugs for which a manufacturer
provides a take back program as part of a Federal Food and Drug Adminis-
tration managed risk evaluation and mitigation strategy; (g) emptied
injector products or emptied medical devices and their component parts
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD09080-01-3
S. 5209 2
or accessories; and (h) drugs that are used solely in a clinical
setting.
§ 2. This act shall take effect on the one hundred eightieth day after
it shall have become a law. Effective immediately, the addition, amend-
ment and/or repeal of any rule or regulation necessary for the implemen-
tation of this act on its effective date are authorized to be made and
completed on or before such effective date.